The Blue Venture Fund
Emir Sandhu, MD, currently serves as Managing Director at The Blue Venture Fund and Sandbox Industries, where investments focus on innovative companies that enhance healthcare and related sectors. Emir Sandhu also holds board positions at Onc.AI, Ultromics, Limber, and observes boards for SonarMD and Octave Bioscience. Emir Sandhu contributes to academic medicine as Adjunct Clinical Faculty in the Dept. of Radiology at Stanford University. Previous experience includes a role as Venture Scholar at Flare Capital Partners. Emir Sandhu's educational background includes an MBA from Harvard Business School, an MD from Harvard Medical School, and a BA in Economics from the University of North Carolina at Chapel Hill.
This person is not in any teams
This person is not in any offices
The Blue Venture Fund
The Blue Venture Fund is a unique collaboration between Blue Cross Blue Shield (BCBS) companies, Blue Cross Blue Shield Association, and Sandbox to which thirty-five BCBS companies have committed over $890 million across four funds. The Blue Venture Fund invests in promising emerging companies of strategic relevance to Blue Cross and/or Blue Shield companies and provides the portfolio with access to BCBS companies to deploy innovation at scale. Sandbox is an independent company that provides healthcare-related investment management exclusively for the Blue Venture Fund.